Skip to content

Understanding a common adverse effect associated with risperidone

4 min read

According to research published by the National Institutes of Health, extrapyramidal symptoms (EPS) were seen in over 36% of patients treated with risperidone in one study. Understanding what is a common adverse effect associated with risperidone is crucial for effective patient management and minimizing potential complications during treatment.

Quick Summary

This guide examines a range of side effects linked to the antipsychotic risperidone, with a focus on extrapyramidal symptoms. It details metabolic changes, endocrine-related issues like hyperprolactinemia, and strategies for managing these adverse effects.

Key Points

  • Extrapyramidal Symptoms (EPS): A classic side effect of risperidone is the risk of EPS, which includes parkinsonism, akathisia, and dystonia.

  • Hyperprolactinemia: Risperidone can significantly elevate prolactin levels, potentially leading to breast enlargement (gynecomastia), milk production (galactorrhea), and sexual dysfunction.

  • Weight Gain: Substantial weight gain is a well-documented adverse effect, particularly in the initial weeks of treatment, and can be linked to other metabolic issues.

  • Metabolic Risks: Besides weight gain, risperidone use is associated with metabolic changes like elevated blood sugar (hyperglycemia) and high cholesterol/triglycerides (dyslipidemia).

  • Sedation and Dizziness: Drowsiness and lightheadedness, especially upon standing (orthostatic hypotension), are common, especially when starting the medication.

  • Management is Possible: Many side effects, including sleep changes and weight gain, can be managed with lifestyle adjustments, dose modification, or additional medication under a doctor's supervision.

In This Article

Risperidone, an atypical antipsychotic, is a medication prescribed to treat conditions like schizophrenia, bipolar disorder, and autism-related irritability. While effective for these conditions, its use is associated with a range of adverse effects that require careful monitoring and management by both patients and healthcare providers. Among the most prominent and frequently reported are extrapyramidal symptoms (EPS), metabolic changes, and hyperprolactinemia.

Extrapyramidal Symptoms (EPS)

Extrapyramidal symptoms are movement-related disorders resulting from the drug's effect on the dopamine receptors in the brain. Risperidone has a potent dopamine D2 receptor antagonism, which can lead to these motor side effects. The specific manifestations can vary in severity and presentation:

  • Parkinsonism: This effect mimics the symptoms of Parkinson's disease, including tremors (shaking, especially of the hands), a shuffling gait, muscle rigidity, and a mask-like facial expression.
  • Akathisia: Characterized by intense feelings of inner restlessness and a compelling urge to move constantly. Patients may pace, shift their weight from foot to foot, or fidget uncontrollably. This can be one of the most distressing side effects and can lead to non-adherence if not addressed.
  • Dystonia: Involves involuntary muscle contractions that cause repetitive twisting or sustained postures. These spasms can affect the face, neck, and back, and may include oculogyric crisis (involuntary upward deviation of the eyes).
  • Tardive Dyskinesia (TD): A long-term risk associated with antipsychotic use, TD involves involuntary, repetitive body movements that can become permanent. Common signs include lip-smacking, tongue movements, and grimacing. The risk of TD increases with treatment duration and cumulative dose.

Hyperprolactinemia and Endocrine Effects

Risperidone's antagonism of the dopamine D2 receptor also leads to another common adverse effect: elevated prolactin levels (hyperprolactinemia). Since dopamine inhibits prolactin release, blocking dopamine receptors removes this inhibition. The consequences of high prolactin levels include:

  • Sexual Dysfunction: This can manifest as decreased libido, erectile dysfunction in men, and irregular or missed menstrual periods (amenorrhea) in women.
  • Gynecomastia and Galactorrhea: This involves breast enlargement in men (gynecomastia) and milk production or discharge from the nipples (galactorrhea) in both men and women.
  • Bone Health Concerns: Sustained hyperprolactinemia may contribute to reduced bone mineral density over time, increasing the risk of osteoporosis.

Metabolic Changes and Weight Gain

Significant weight gain is a common and concerning adverse effect of risperidone, occurring in a substantial percentage of patients, especially children and adolescents. Up to 20% of users may gain over 7% of their baseline weight shortly after starting treatment. This weight gain is part of broader metabolic changes that can increase cardiovascular and cerebrovascular risks. These changes include:

  • Increased Appetite: Many patients report an increase in appetite, which directly contributes to weight gain.
  • Hyperglycemia and Diabetes: Atypical antipsychotics, including risperidone, have been associated with elevated blood sugar levels and, in some cases, the onset of diabetes mellitus. Regular monitoring of blood glucose is recommended.
  • Dyslipidemia: Risperidone use can lead to undesirable changes in blood lipids, such as high cholesterol and triglycerides.

Other Common Side Effects

Beyond EPS, hyperprolactinemia, and metabolic issues, other frequent adverse effects include:

  • Sedation and Dizziness: Drowsiness and fatigue are commonly reported, especially early in treatment. This can impair judgment and motor skills.
  • Orthostatic Hypotension: This is a drop in blood pressure when standing up, which can cause dizziness, lightheadedness, and fainting, increasing the risk of falls, particularly in the elderly.
  • Gastrointestinal Issues: Patients may experience nausea, vomiting, constipation, or diarrhea.

Comparison of Adverse Effects: Risperidone vs. Other Antipsychotics

Risperidone's side effect profile differs from other atypical antipsychotics, which is an important consideration for treatment decisions.

Side Effect Category Risperidone Olanzapine Quetiapine
Extrapyramidal Symptoms (EPS) Higher risk than many other atypical antipsychotics Lower risk compared to risperidone Lower risk compared to risperidone
Hyperprolactinemia Associated with significantly higher prolactin levels than most other atypical antipsychotics Lower prolactin-elevating effect Lower prolactin-elevating effect
Weight Gain Associated with significant weight gain, though generally less than olanzapine Higher risk of weight gain than risperidone Moderate risk of weight gain
Sedation Can cause somnolence, but may be less sedating than some other agents Sedation is a common side effect Often highly sedating

Managing Adverse Effects

Proactive strategies are crucial for minimizing discomfort and promoting treatment adherence.

For Extrapyramidal Symptoms:

  • Your doctor may adjust the dose of risperidone or add a supplementary medication to counteract the movement issues.
  • Monitoring for signs of tardive dyskinesia is essential for early detection.

For Hyperprolactinemia:

  • If symptoms are severe, your doctor might consider switching to a different antipsychotic with a lower risk of prolactin elevation.
  • Regular monitoring of prolactin levels is important, especially for younger patients.

For Metabolic Changes:

  • A healthy diet rich in fruits, vegetables, and whole grains can help manage weight gain.
  • Regular exercise is recommended to help stabilize weight.
  • Blood glucose and cholesterol should be monitored regularly by your healthcare provider.

For Sedation and Dizziness:

  • Taking risperidone in the evening may help mitigate daytime drowsiness.
  • To prevent orthostatic hypotension, rise slowly from a sitting or lying position.

Conclusion

Extrapyramidal symptoms, alongside hyperprolactinemia and metabolic changes, represent classic and common adverse effects associated with risperidone. While these side effects can be challenging, awareness and proactive management are key to mitigating their impact. Open communication with a healthcare team is vital to ensure an optimal balance between managing the underlying psychiatric condition and addressing potential medication-related side effects. Treatment should always be individualized, with dosages periodically reassessed to maintain the best clinical response with the fewest side effects. For more detailed information on managing risperidone's side effects, consulting reliable health resources is recommended.

Managing Risperidone Side Effects

Frequently Asked Questions

Extrapyramidal symptoms (EPS) are movement-related disorders caused by risperidone's effect on dopamine receptors. They include parkinsonism (tremors, rigidity), akathisia (restlessness), and dystonia (involuntary muscle contractions).

Yes, significant weight gain is a common adverse effect associated with risperidone use. It is often accompanied by an increased appetite and can contribute to other metabolic health issues.

Hyperprolactinemia is the elevation of prolactin levels in the blood, caused by risperidone's action on dopamine receptors. Symptoms can include breast enlargement and milk production in both men and women, as well as sexual dysfunction and menstrual irregularities.

Tardive dyskinesia (TD) is a serious, long-term side effect involving involuntary movements of the face and body. While risperidone is an atypical antipsychotic with a lower risk than older drugs, TD is still a potential concern, and long-term monitoring is advised.

Drowsiness can often be managed by adjusting the timing of your medication dose. Taking the full daily dose at bedtime, if recommended by your doctor, can help reduce daytime sleepiness.

Dizziness and unsteadiness, particularly when standing up, are common and are often caused by orthostatic hypotension. Rising slowly from a sitting or lying position can help. If the symptoms are severe or cause fainting, contact your healthcare provider immediately.

Yes, older adults with dementia-related psychosis have an increased risk of death when taking risperidone and a higher risk of stroke. For this reason, the FDA has not approved its use in patients with dementia-related psychosis.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.